News | Artificial Intelligence | April 02, 2020

Vuno offers a suite of AI solutions for COVID-19

The web-based services available for free for anyone who wants to use our AI algorithms to analyze a chest X-ray or CT scan

#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 the company is now offering a suite of AI solutions Vuno Med-LungQuant and Vuno Med-Chest X-ray for COVID-19, encompassing both lung X-ray and computed tomography (CT) modalities respectively all at once
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 the company is now offering a suite of AI solutions Vuno Med-LungQuant and Vuno Med-Chest X-ray for COVID-19, encompassing both lung X-ray and computed tomography (CT) modalities respectively all at once

April 2, 2020 — In the face of the COVID-19 pandemic raging around the globe, Vuno has decided to move quickly by joining the global coalition to help address some critical issues facing the international healthcare community today by putting artificial intelligence (AI) into work. A spokesperson said that Vuno has been inundated with requests over the last several weeks regarding how it can help doctors remain resilient and better respond to the spread of the infection and ultimately contribute to saving lives.

In an effort to help the medical community, Vuno has accelerated the development and enhancement of its exiting AI algorithms to better meet the specific needs and demands from exhausted doctors who willingly put themselves at risk to save lives in the fight against COVID-19.

With that mission in mind, the company is now offering a suite of AI solutions Vuno Med-LungQuant and Vuno Med-Chest X-ray for COVID-19, encompassing both lung X-ray and computed tomography (CT) modalities respectively all at once. Our one-stop service offering will allow users to choose one or both algorithms to use depending on their own needs by simply visiting one website without the hassle of moving from different AI systems.

The special versions of two AI products for COVID-19 were released this week. These are web-based services available at https://covid19.vunomed.com/ for free for anyone who wants to use theAI algorithms to analyze a chest X-ray or CT scan.

AI Solutions Offered

The common theme of the two AI solutions is to empower healthcare providers to provide better patient care by assisting them in the screening, diagnosis and management of COVID-19 infected patients using our AI technology. They are developed to help protect healthcare providers from burnout or help overworked doctors on the edge of exhaustion in virus fight make a speedier and more accurate diagnostic decision in a difficult time like now. In addition, our cloud-based service offering will enable remote result reading and tracking of the status of patients infected with COVID-19, where radiologists are not readily available.  

In Korea, two local governments in Gangwon Province and a major hospital in Daegu, the hardest-hit area are actively using VUNO Med-Chest X-ray in response to the outbreak. They stated that the instant and visualized results with a colored heatmap from the solution are very helpful to triage patients with suspected infection of the virus, especially when they cannot see the X-ray images clearly due to fogged goggles they have to wear all day long. 

Medical institutions and healthcare providers are encouraged to make the best use of the free online service offering available at https://covid19.vunomed.com/

Related Coronavirus Content:

Two Studies Use SIRD Model to Forecast COVID-19 Spread

Radiology Publishes First Case of COVID-19 Encephalopathy

VIDEO: Use of Telemedicine in Medical Imaging During COVID-19

VIDEO: How China Leveraged Health IT to Combat COVID-19

 CDRH Issues Letter to Industry on COVID-19

Qure.ai Launches Solutions to Help Tackle COVID19 

ASRT Deploys COVID-19 Resources for Educational Programs

Study Looks at CT Findings of COVID-19 Through Recovery

VIDEO: Imaging COVID-19 With Point-of-Care Ultrasound (POCUS)

The Cardiac Implications of Novel Coronavirus

CT Provides Best Diagnosis for Novel Coronavirus (COVID-19)

Radiology Lessons for Coronavirus From the SARS and MERS Epidemics

Deployment of Health IT in China’s Fight Against the COVID-19 Epidemic

Emerging Technologies Proving Value in Chinese Coronavirus Fight

Radiologists Describe Coronavirus CT Imaging Features

Coronavirus Update from the FDA

CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) Pneumonia

CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)

Chest CT Findings of Patients Infected With Novel Coronavirus 2019-nCoV Pneumonia 

Find more related clinical content Coronavirus (COVID-19)

Related Content

The artificial intelligence-driven Caption Guidance software guides point of care ultrasound (POCUS) users to get optimal cardiac ultrasound images. The AI software is an example of a FDA-cleared software that is helping improve imaging, even when used by less experienced users.

The artificial intelligence-driven Caption Guidance software guides point of care ultrasound (POCUS) users to get optimal cardiac ultrasound images. The AI software is an example of a FDA-cleared software that is helping improve imaging, even when used by less experienced users.

Feature | Artificial Intelligence | September 29, 2020 | Joe Fornadel, J.D., and Wes Moran, J.D.
The number of Federal Drug Administration (FDA)-approved AI-based algorithms is significant and has grown at a steady
The FDA Center for Devices and Radiological Health's COVID-19 response by the numbers between January 1 and September 18, 2020.

The FDA Center for Devices and Radiological Health's COVID-19 response by the numbers between January 1 and September 18, 2020. Graphic courtesy of FDA

News | Coronavirus (COVID-19) | September 29, 2020
September 29, 2020 — On September 28, FDA Commissioner of Food and Drugs...
Lung and respiratory health pioneer paves way for more precise care of complex respiratory conditions
News | Artificial Intelligence | September 25, 2020
September 25, 2020 — VIDA Diagnostics, Inc. announced that it has received 510(k) clearance from the Food and Drug Ad
EchoGo Pro automates cardiac ultrasound measurements for heart functions, but also empower physicians to predict the occurrence of coronary artery disease (CAD).

EchoGo Pro automates cardiac ultrasound measurements for heart functions, but also empower physicians to predict the occurrence of coronary artery disease (CAD).

News | Cardiovascular Ultrasound | September 25, 2020
September 25, 2020 — Based on its recent analysis of the global...